NCT02713854 is a NA clinical trial of endometrial biopsy in Subfertility, sponsored by The University of Hong Kong.

Who is sponsoring NCT02713854?

NCT02713854 is sponsored by The University of Hong Kong.

What drugs are being tested in NCT02713854?

Interventions in NCT02713854: endometrial biopsy.

What condition does NCT02713854 study?

NCT02713854 studies Subfertility.

Is NCT02713854 still recruiting?

NCT02713854 is currently completed. Last updated 4 March 2022.

Last reviewed 2022-03-04 · How we verify

NCT02713854

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

BAP-EB as a Predictive Tool for Endometrial Receptivity and Pregnancy Outcome of IVF Treatment

Completed NA Last updated 4 March 2022

What this trial tests

NA trial testing endometrial biopsy in Subfertility in 240 participants. Completed in 13 September 2021.

Timeline

1 February 2017

Primary endpoint
4 July 2020

13 September 2021

Quick facts

Lead sponsor	The University of Hong Kong
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	diagnostic
Enrollment	240
Start date	1 February 2017
Primary completion	4 July 2020
Estimated completion	13 September 2021
Sites	1 location across China

Drugs / interventions tested

endometrial biopsy

Conditions studied

Subfertility — all drugs for Subfertility →

Sponsor

The University of Hong Kong

Who can join

Adults 18 to 42, female only, with Subfertility. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To determine the predictive value of attachment rate of human embryonic stem cells (hESC)-derived trophoblast spheroids (BAP-EB, embryo surrogate) onto endometrial epithelial cells (EEC) on success of IVF treatment and to use the model to identify EEC surface biomarkers for endometrial receptivity.

Publications & conference data

4 peer-reviewed publications reference this trial (live from Europe PMC):

Application of Stem Cell Therapy for Infertility.
Saha S, Roy P, Corbitt C, Kakar SS. · · 2021 · cited 54× · PMID 34203240 · DOI 10.3390/cells10071613
Advancements in Human Embryonic Stem Cell Research: Clinical Applications and Ethical Issues.
Park SJ, Kim YY, Han JY, Kim SW, et al · · 2024 · cited 29× · PMID 38502279 · DOI 10.1007/s13770-024-00627-3
Attachment of a trophoblastic spheroid onto endometrial epithelial cells predicts cumulative live birth in women aged 35 and older.
Lee YL, Ruan H, Lee KC, Fong SW, et al · · 2023 · cited 6× · PMID 36940739 · DOI 10.1016/j.fertnstert.2023.03.013
Addressing the challenges of immunogenicity, heterogeneity and tumorigenicity in the clinical translation of human embryonic stem cells.
Xia L, Qin J, Ye S. · · 2025 · PMID 41291912 · DOI 10.1186/s13287-025-04826-0

Verify or expand the search:

Other trials of endometrial biopsy

Trials testing the same drug.

NCT07496905 — The Effect of the Valsalva Maneuver in Endometrial Biopsy: A Randomized Controlled Trial · NA · recruiting
NCT04079959 — Endometrial Leucocytes Around the Time of Embryo Implantation in Women Undergoing in IVF-ET · unknown
NCT02522806 — Endometrial Local Injury Before First IVF : Evaluation of Pregnancy Rate · NA · completed
NCT02197923 — Norwegian Adenomyosis Study II: Gene Expression Profiling of Adenomyosis · unknown

Other recruiting trials for Subfertility

Currently open trials in the same condition.

NCT07375238 — Effect of Daily Intake of Gazpacho on Semen Quality and Oxidative Stress · NA · recruiting
NCT05876234 — The Predictive Value of Progesterone · active not recruiting
NCT05328999 — Fertility and the Microbiome · recruiting
NCT03859921 — Oral Dydrogesterone as Luteal Phase Support in Natural Cycle FET · Phase 3 · recruiting
NCT04064840 — GnRH Agonist for Dual Trigger in IVF and for Luteal Phase Support in FET · Phase 3 · recruiting

Other The University of Hong Kong trials

Trials by the same sponsor.

NCT05981430 — Fecal Microbiota Transplantation for Decolonization of Carbapenem-resistant Enterobacteriaceae · NA · not yet recruiting
NCT07478757 — Assessing the Effectiveness of Low-Dose Computed Tomography in Lung Cancer Screening for High-Risk Smokers: A Randomized · NA · not yet recruiting
NCT07448649 — Chatbot-Assisted Advance Care Planning Education for Family Members · NA · not yet recruiting
NCT07484932 — TRTRM (ACTTOP) -Guided Dosing Strategy in Older Patients With Cancer · NA · not yet recruiting
NCT07531589 — BrainLive Connect: Non-professional Delivered CST for People Living With Dementia · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02713854 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by The University of Hong Kong
Last refreshed: 4 March 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02713854.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing